Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 10-2006 | 09-2006 | 07-2006 | 06-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,400 | -1,406 | N/A | -711 | -4,060 |
| Depreciation Amortization | 580 | 84 | 230 | 42 | 260 |
| Accounts receivable | N/A | 63 | N/A | 32 | N/A |
| Other Working Capital | 300 | 305 | 220 | 225 | -40 |
| Other Operating Activity | 40 | 471 | 10 | 176 | 1,700 |
| Operating Cash Flow | $-480 | $-484 | $460 | $-235 | $-2,140 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | N/A | 0 | N/A | -20 |
| Other Investing Activity | -10 | -12 | 0 | -6 | -30 |
| Investing Cash Flow | $-10 | $-12 | $N/A | $-6 | $-50 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 597 | N/A | 248 | N/A |
| Other Financing Activity | 590 | 0 | 240 | 0 | 1,610 |
| Financing Cash Flow | $590 | $597 | $240 | $248 | $1,610 |
| Beginning Cash Position | 0 | 0 | N/A | 0 | 580 |
| End Cash Position | 100 | 102 | N/A | 8 | 0 |
| Net Cash Flow | $100 | $102 | $700 | $7 | $-580 |
| Free Cash Flow | |||||
| Operating Cash Flow | -480 | -484 | 460 | -235 | -2,140 |
| Free Cash Flow | -480 | -484 | 460 | -235 | -2,140 |